Abstract
Purpose
Obesity is associated with an increased risk of papillary thyroid carcinoma (PTC). Evidence of the impact of obesity on PTC aggressiveness is scarce. We aimed to evaluate the association between the body mass index (BMI) and the presence of aggressive features of low- to intermediate-risk PTC in a prospective cohort.
Methods
We prospectively enrolled 1,032 patients with low- to intermediate-risk PTC who underwent lobectomy at 22 hospitals in Korea and divided into three groups according to BMI, as follows: normal/underweight ( < 23 kg/m2), overweight (23–24.9 kg/m2), and obese ( ≥ 25 kg/m2). Clinicopathological features of PTC at diagnosis were evaluated.
Results
Obese patients had a higher rate of macro-PTC ( > 1 cm) and greater incidence of extra-thyroidal extension (ETE), vascular invasion, and intermediate-risk tumors than those not classified as obese. Increased BMI was positively associated with the incidence of macro-PTC, ETE, vascular invasion, and intermediate-risk category. After adjusting for age, sex, pathological features, metabolic syndrome, thyroid function test, and smoking habits, obesity was a risk factor for ETE (odds ratio [OR] = 1.7, 95% confidence interval [CI]: 1.2–2.5, p = 0.005) and intermediate-risk PTC (OR = 1.7, 95% CI: 1.1–2.5, p = 0.011) in women. The association between obesity and ETE was significant regardless of whether or not women had metabolic syndrome. There was no significant association between obesity and aggressive PTC features in men.
Conclusion
BMI at the time of thyroid cancer diagnosis may affect the aggressiveness of low- to intermediate-risk PTC, especially in women.
Similar content being viewed by others
References
L. Davies, H.G. Welch, Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. 140(4), 317–322 (2014)
M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono, E.C. Mullany, S. Biryukov, C. Abbafati, S.F. Abera, J.P. Abraham, N.M. Abu-Rmeileh, T. Achoki, F.S. AlBuhairan, Z.A. Alemu, R. Alfonso, M.K. Ali, R. Ali, N.A. Guzman, W. Ammar, P. Anwari, A. Banerjee, S. Barquera, S. Basu, D.A. Bennett, Z. Bhutta, J. Blore, N. Cabral, I.C. Nonato, J.C. Chang, R. Chowdhury, K.J. Courville, M.H. Criqui, D.K. Cundiff, K.C. Dabhadkar, L. Dandona, A. Davis, A. Dayama, S.D. Dharmaratne, E.L. Ding, A.M. Durrani, A. Esteghamati, F. Farzadfar, D.F. Fay, V.L. Feigin, A. Flaxman, M.H. Forouzanfar, A. Goto, M.A. Green, R. Gupta, N. Hafezi-Nejad, G.J. Hankey, H.C. Harewood, R. Havmoeller, S. Hay, L. Hernandez, A. Husseini, B.T. Idrisov, N. Ikeda, F. Islami, E. Jahangir, S.K. Jassal, S.H. Jee, M. Jeffreys, J.B. Jonas, E.K. Kabagambe, S.E. Khalifa, A.P. Kengne, Y.S. Khader, Y.H. Khang, D. Kim, R.W. Kimokoti, J.M. Kinge, Y. Kokubo, S. Kosen, G. Kwan, T. Lai, M. Leinsalu, Y. Li, X. Liang, S. Liu, G. Logroscino, P.A. Lotufo, Y. Lu, J. Ma, N.K. Mainoo, G.A. Mensah, T.R. Merriman, A.H. Mokdad, J. Moschandreas, M. Naghavi, A. Naheed, D. Nand, K.M. Narayan, E.L. Nelson, M.L. Neuhouser, M.I. Nisar, T. Ohkubo, S.O. Oti, A. Pedroza, D. Prabhakaran, N. Roy, U. Sampson, H. Seo, S.G. Sepanlou, K. Shibuya, R. Shiri, I. Shiue, G.M. Singh, J.A. Singh, V. Skirbekk, N.J. Stapelberg, L. Sturua, B.L. Sykes, M. Tobias, B.X. Tran, L. Trasande, H. Toyoshima, S. van de Vijver, T.J. Vasankari, J.L. Veerman, G. Velasquez-Melendez, V.V. Vlassov, S.E. Vollset, T. Vos, C. Wang, X. Wang, E. Weiderpass, A. Werdecker, J.L. Wright, Y.C. Yang, H. Yatsuya, J. Yoon, S.J. Yoon, Y. Zhao, M. Zhou, S. Zhu, A.D. Lopez, C.J. Murray, E. Gakidou, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945), 766–781 (2014)
A. Engeland, S. Tretli, L.A. Akslen, T. Bjørge, Body size and thyroid cancer in two million Norwegian men and women. Br. J. Cancer 95(3), 366–370 (2006)
C.M. Kitahara, M.L. McCullough, S. Franceschi, S. Rinaldi, A. Wolk, G. Neta, H. Olov Adami, K. Anderson, G. Andreotti, L.E. Beane Freeman, L. Bernstein, J.E. Buring, F. Clavel-Chapelon, L.A. De Roo, Y.T. Gao, J.M. Gaziano, G.G. Giles, N. Håkansson, P.L. Horn-Ross, V.A. Kirsh, M.S. Linet, R.J. MacInnis, N. Orsini, Y. Park, A.V. Patel, M.P. Purdue, E. Riboli, K. Robien, T. Rohan, D.P. Sandler, C. Schairer, A.B. Schneider, H.D. Sesso, X.O. Shu, P.N. Singh, P.A. van den Brandt, E. Ward, E. Weiderpass, E. White, Y.B. Xiang, A. Zeleniuch-Jacquotte, W. Zheng, P. Hartge, A. Berrington de González, Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid 26(2), 306–318 (2016)
B. Lauby-Secretan, C. Scoccianti, D. Loomis, Y. Grosse, F. Bianchini, K. Straif, Body fatness and cancer-viewpoint of the IARC working group. N. Engl. J. Med. 375(8), 794–798 (2016)
H.J. Kim, N.K. Kim, J.H. Choi, S.Y. Sohn, S.W. Kim, S.M. Jin, H.W. Jang, S. Suh, Y.K. Min, J.H. Chung, S.W. Kim, Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin. Endocrinol. (Oxf.) 78(1), 134–140 (2013)
C. Trésallet, M. Seman, F. Tissier, C. Buffet, R.M. Lupinacci, H. Vuarnesson, L. Leenhardt, F. Menegaux, The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery 156(5), 1145–1152 (2014)
Matrone, A., Ceccarini, G., Beghini, M., Ferrari, F., Gambale, C., D’Aqui, M., Piaggi, P., Torregrossa, L., Molinaro, E., Basolo, F., Vitti, P., Santini, F., Elisei, R. Potential impact of BMI on the aggressiveness of presentation and clinical outcome of differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 105 (4) (2020).
H. Kwon, M. Kim, Y.M. Choi, E.K. Jang, M.J. Jeon, W.G. Kim, T.Y. Kim, Y.K. Shong, D.E. Song, J.H. Baek, S.J. Hong, W.B. Kim, Lack of associations between body mass index and clinical outcomes in patients with papillary thyroid carcinoma. Endocrinol. Metab. (Seoul) 30(3), 305–311 (2015)
J.E. Paes, K. Hua, R. Nagy, R.T. Kloos, D. Jarjoura, M.D. Ringel, The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J. Clin. Endocrinol. Metab. 95(9), 4244–4250 (2010)
C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12(11), 646–653 (2016)
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)
Y.S. Lee, H.S. Chang, C.S. Park, Changing trends in the management of well-differentiated thyroid carcinoma in Korea. Endocr. J. 63(6), 515–521 (2016)
Y. Ito, A. Miyauchi, M. Kihara, T. Higashiyama, K. Kobayashi, A. Miya, Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1), 27–34 (2014)
E.K. Lee, Y.E. Kang, Y.J. Park, B.S. Koo, K.-W. Chung, E.J. Ku, H.-R. Won, W.S. Yoo, E. Jeon, S.H. Paek, Y.S. Lee, D.M. Lim, Y.J. Suh, H.K. Park, H.-J. Kim, B.H. Kim, M. Kim, S.W. Kim, K.H. Yi, S.K. Park, E.-J. Jung, J.Y. Choi, J.S. Bae, J.H. Hong, K.-H. Nam, Y.K. Lee, H.W. Yu, S. Go, Y.M. Kang, A. Multicenter, Randomized, controlled trial for assessing the usefulness of suppressing thyroid stimulating hormone target levels after thyroid lobectomy in low to intermediate risk thyroid cancer patients (MASTER): A study protocol. Endocrinol. Metab. 36(3), 574–581 (2021)
N.D. Perrier, J.D. Brierley, R.M. Tuttle, Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J. Clin. 68(1), 55–63 (2018)
World Health Organization, R.O.f.t.W.P.: The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Health Communications Australia, Sydney, Australia (2000).
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285(19), 2486–2497 (2001).
S.H. Kim, H.S. Park, K.H. Kim, H. Yoo, B.J. Chae, J.S. Bae, S.S. Jung, B.J. Song, Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer. Surg. Today 45(6), 723–729 (2015)
C.L. Li, G. Dionigi, Y.S. Zhao, N. Liang, H. Sun, Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors. J. Endocrinol. Invest. 43(9), 1283–1299 (2020)
M.D. Bortz, K. Kuchta, D.J. Winchester, R.A. Prinz, T.A. Moo-Young, Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer. Surgery 169(1), 2–6 (2021)
Z. Liu, Y. Huang, S. Chen, D. Hu, M. Wang, L. Zhou, W. Zhou, D. Chen, H. Feng, W. Wei, C. Zhang, W. Zeng, L. Guo, Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system? PLoS One 14(6), e0218171 (2019)
J.S. Choi, E.K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine 48(1), 264–271 (2015)
C. Feng, Y. Gao, C. Wang, X. Yu, W. Zhang, H. Guan, Z. Shan, W. Teng, Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 98(9), E1524–E1533 (2013)
H. Kwon, Y. Chang, A. Cho, J. Ahn, S.E. Park, C.Y. Park, W.Y. Lee, K.W. Oh, S.W. Park, H. Shin, S. Ryu, E.J. Rhee, Metabolic obesity phenotypes and thyroid cancer risk: a cohort study. Thyroid 29(3), 349–358 (2019)
A. Matrone, F. Ferrari, F. Santini, R. Elisei, Obesity as a risk factor for thyroid cancer. Curr. Opin. Endocrinol. Diab. Obes. 27(5), 358–363 (2020)
C. Ranasinghe, P. Gamage, P. Katulanda, N. Andraweera, S. Thilakarathne, P. Tharanga, Relationship between Body Mass Index (BMI) and body fat percentage, estimated by bioelectrical impedance, in a group of Sri Lankan adults: a cross sectional study. BMC Public Health 13, 797 (2013)
Funding
This study was supported by a grant from the Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HI19C0481, HC19C0103).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The study protocol was reviewed and approved by the Institutional Review Board of each participating institution (trial registration number: KCT0004989).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kim, M., Kang, Y.E., Park, Y.J. et al. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study. Endocrine 82, 134–142 (2023). https://doi.org/10.1007/s12020-023-03416-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03416-5